CLINICAL_TRIALS
trial_result
· 2013-05-30
Clinical Trial Update: Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors [Phase 1]
Summary
A Phase 1 study assessing the safety and pharmacokinetics of XL765 (SAR245409) in adults with solid tumors has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Cancer | Phase 1 | Status: COMPLETED